medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01 Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India
Published January 15, 2025 · Recall initiated: December 18, 2024
Summary
FDA records drug Class II recall D-0185-2025, published January 15, 2025 and initiated December 18, 2024. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 19872 vials; Lot: Lot No.: 1MP24069, Exp.: 08/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Get an email if MEDROXYPROGESTERONE ACETATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MEDROXYPROGESTERONE ACETATE
- Manufacturer
- Eugia US LLC
- Distributor
- Nationwide in the US
- UPC
- 0355150330010
- Lot
- Lot No.: 1MP24069, Exp.: 08/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, AmnealJanuary 15, 2025
- FDAProgesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for:January 15, 2025
- FDAMethadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: HikmaJanuary 15, 2025
- FDAColchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc.January 15, 2025
- FDACiprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, DistributedJanuary 15, 2025
- FDAmedroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only,June 22, 2022
Questions about this recall
Was medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01 Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India recalled?
Yes. FDA published recall D-0185-2025 on January 15, 2025. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MEDROXYPROGESTERONE ACETATE. UPC: 0355150330010.